Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 4Phase 4 2Phase 1/2 2

Status

Unknown 7Completed 2Suspended 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Completed × icotinib × Clear all
NCT02744664 2020-05-27

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Fuda Cancer Hospital, Guangzhou

Phase 4 Completed
60 enrolled
Thoracic

Lung Neoplasms

NCT01465243 2014-02-17

Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose

Betta Pharmaceuticals Co., Ltd.

Phase 4 Completed
32 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡